Helicobacter Pylori Non-Invasive Testing Market Trends and Growth Forecast by 2033Posted by Ganesh Shinde on December 21st, 2022 The global Helicobacter Pylori Non-Invasive Testing Market is projected to register at a moderate-paced CAGR of 4.4% over the forecast period. The helicobacter pylori non-invasive testing market is currently valued at US$ 650.50 Mn in 2023. By 2033, demand for helicobacter pylori non-invasive testing is expected to reach a high of US$ 1000.57 Mn. The growth of the helicobacter pylori non-invasive testingmarket is expected to be spurred by factors such as the increasing prevalence of Helicobacter pylori bacterial infection, increased governmental awareness about infection for accurate diagnosis, and the launch of new products and the approval of those products by the Food and Drug Administration. Although the demand for helicobacter pylori non-invasive testing has potential, it is unlikely to develop due to problems like a low detection rate, the absence of any outward symptoms, and stringent regulatory constraints. However, doctors have still advised patients to get treatment for H. Pylori infections as soon as feasible, despite the lack of evidence linking COVID-19 and the virus. Market share for non-invasive testing for Helicobacter pylori (H. pylori) is highest in North America, while growth is quickest in Asia-Pacific. Due to rising rates of gastric cancer, duodenal ulcers, and gastric ulcers, as well as the improvement of healthcare infrastructure, the North American helicobacter pylori non-invasive testingmarket is anticipated to expand throughout the forecast period. During the forecast period, the market for non-invasive tests for H. pylori is expected to grow at a rate greatest in Asia Pacific. China, India, and Japan are just a few of the countries in the region where the demand for helicobacter pylori non-invasive testing is anticipated to expand at a rapid rate in the future years. As the ageing population in Asia and the Pacific rises, along with the frequency of Helicobacter pylori (H. pylori) and gastric cancer cases, the market for non-invasive testing of H. pylori is projected to expand. That's why there's so much opportunity for development in the region throughout the predicted expansion period for helicobacter pylori non-invasive testingmarket players. Competitive Landscape The global helicobacter pylori non-invasive testing market comprises of the following players: Meridian Bioscience, Inc., DiaSorin S.p.A, Alere, Sekiusi Diagnostics and Biomerica, Inc. Besides these, a host of other players have a significant market presence as well. These are Biohit Oyj, Exalenz Bioscience Ltd., Aalto Bio Reagents Ltd., Certest Biotec S.L. and CorisBioconcept SPRL. Key Segments in the Helicobacter Pylori Non-Invasive Testing Market By Non-invasive Test Type:
By Test Type:
By End-user:
Read More@ https://www.futuremarketinsights.com/reports/helicobacter-pylori-non-invasive-testing-market Like it? Share it!More by this author |